Home LiteratureArticle Details
PMID: 9655888 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury.

The Journal of pharmacology and experimental therapeutics ·Vol. 286 ·No. 1 ·1998-07-00 ·Pages 429-38

Buerke M, Prüfer D, Dahm M, Oelert H, Meyer J, Darius H

Abstract

Myocardial injury after ischemia (I) and reperfusion (R) is related to leukocyte activation with subsequent release of cytokines and oxygen-derived free radicals as well as complement activation. In our study, the cardioprotective effects of exogenous C1 esterase inhibitor (C1 INH) were examined in a rat model of myocardial I + R (i.e., 20 min + 24 hr or 48 hr). The C1 INH (10, 50 and 100 U/kg) administered 2 min before reperfusion significantly attenuated myocardial injury after 24 hr of R compared to vehicle treated rats (P < .001). Further, cardiac myeloperoxidase activity (i.e., a marker of PMN [polymorphonuclear leukocyte] accumulation) in the ischemic area was significantly reduced after C1 INH treatment compared to vehicle treated animals (0.81 +/- 0.1, 0.34 +/- 0.13, 0.13 +/- 0.1 vs. 1.44 +/- 0.3 U/100 mg tissue, P < .001). In addition, C1 INH (100 U/kg) significantly attenuated myocardial injury and neutrophil infiltration even after 48 hr of reperfusion compared to vehicle treatment. Immunohistochemical analysis of ischemic-reperfused myocardial tissue demonstrated activation of classical complement pathway by deposition of C1q on cardiac myocytes and cardiac vessels. In addition, expression of the endothelial adhesion molecules P-selectin and intercellular adhesion molecule 1 (ICAM-1) was observed after reperfusion of the ischemic myocardium. In this regard, C1 INH administration abolished expression of P-selectin and ICAM-1 on the cardiac vasculature after myocardial ischemia and reperfusion. Blocking the classical complement pathway by exogenous C1 INH appears to be an effective means to preserve ischemic myocardium from injury after 24 and 48 hr of reperfusion. The mechanisms of this cardioprotective effect appears to be due to blocking of complement activation and reduced endothelial adhesion molecule expression with subsequent reduced PMN-endothelium interaction, resulting in diminished cardiac necrosis.

MeSH Terms
Animals Complement C1 Inactivator Proteins/pharmacology Complement C1q/analysis Complement Pathway, Classical Endothelium, Vascular/chemistry Hemolysis Humans Immunohistochemistry Intercellular Adhesion Molecule-1/analysis Male Myocardial Reperfusion Injury/prevention & control Neutrophils/physiology P-Selectin/analysis Rats Rats, Sprague-Dawley
Chemicals
Complement C1 Inactivator Proteins P-Selectin Intercellular Adhesion Molecule-1 Complement C1q
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Buerke M
II. Department of Medicine, Johannes Gutenberg University, Mainz, Germany.
Prüfer D
Dahm M
Oelert H
Meyer J
Darius H
Article Info
Journal
The Journal of pharmacology and experimental therapeutics
Abbr.
J Pharmacol Exp Ther
ISSN
0022-3565
Published
1998-07-00
Pages
429-38
Language
English
Region
United States
NLM ID
0376362
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com